The mineralocorticoid receptor and its coregulators

Journal of Molecular Endocrinology

Volumn 43, Issue 2, 2009, Pages 53-64

  Yang, Jun ^a   Young, Morag J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DAXX PROTEIN; ELONGATION FACTOR; FAS ANTIGEN; MINERALOCORTICOID RECEPTOR; NUCLEAR FACTOR Y; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COREPRESSOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT1; PROTEIN UBC9; RECEPTOR INTERACTING PROTEIN 140; RNA HELICASE; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTIONAL INTERMEDIARY FACTOR 1 ALPHA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; NUCLEAR RECEPTOR CO-REPRESSOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ENZYME ACTIVATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STEROID BINDING; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRANSCRIPTION INITIATION;

DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HUMANS; PPAR GAMMA; RECEPTORS, MINERALOCORTICOID; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 69849091806     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-09-0031     Document Type: Review

References (134)

1. Alnemri ES, Maksymowych AB, Robertson NM & Litwack G 1991 Overexpression and characterization of the human mineralocorticoid receptor. Journal of Biological Chemistry 266 18072-18081. (Pubitemid 21908049)
2. Alzamora R, Michea L & Marusic ET 2000 Role of 11{beta}- hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 35 1099-1104.
3. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM & Meltzer PS 1997 AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277 965-968. (Pubitemid 27366683)
4. Auboeuf D, Honig A, Berget SM & O'Malley BW 2002 Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298 416-419. (Pubitemid 35176350)
5. Baker ME, Chandsawangbhuwana C & Ollikainen N 2007 Structural analysis of the evolution of steroid specificity in the mineralocorticoid and glucocorticoid receptors. BMC Evolutionary Biology 7 24. (Pubitemid 46334077)
6. Bledsoe RK, Madauss KP, Holt JA, Apolito CJ, Lambert MH, Pearce KH, Stanley TB, Stewart EL, Trump RP, Willson TM et al. 2005 A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. Journal of Biological Chemistry 280 31283-31293.
7. Bocchi B, Fagart J, Cluzeaud F, Fay M, Rafestin-Oblin M-E & Farman N 2003 Glucocorticoid metabolism by 11-beta hydroxysteroid dehydrogenase type 2 modulates human mineralocorticoid receptor transactivation activity. Journal of Steroid Biochemistry and Molecular Biology 84 239-244. (Pubitemid 36514840)
8. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM & Mangelsdorf DJ 2006 Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 789-799. (Pubitemid 44233630)
9. Bouras T, Southey MC & Venter DJ 2001 Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Research 61 903-907. (Pubitemid 32174400)
10. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M & Zennaro M-C 2007 Pivotal role of themineralocorticoid receptor in corticosteroidinduced adipogenesis. FASEB Journal 21 2185-2194. (Pubitemid 47026453)
11. Centenera MM, Harris JM, Tilley WD & Butler LM 2008 The contribution of different androgen receptor domains to receptor dimerization and signaling. Molecular Endocrinology 22 2373-2382.
12. Chang C-Y & McDonnell DP 2005 Androgen receptor-cofactor interactions as targets for new drug discovery. Trends in Pharmacological Sciences 26 225-228. (Pubitemid 40603069)
13. Chang C-Y, Norris JD, Gron H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D & McDonnell DP 1999 Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Molecular and Cellular Biology 19 8226-8239. (Pubitemid 30414017)
14. Chang C-Y, Abdo J, Hartney T & McDonnell DP 2005 Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Molecular Endocrinology 19 2478-2490. (Pubitemid 41362662)
15. Chen JD & Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 454-457.
16. Christy C, Hadoke PW, Paterson JM, Mullins JJ, Seckl JR & Walker BR 2003 11{beta}-Hydroxysteroid dehydrogenase type 2 inmouse aorta: localization and influence on response to glucocorticoids. Hypertension 42 580-587. (Pubitemid 37237357)
17. Clyne CD, Chang C-Y, Safi R, Fuller PJ, McDonnell DP & Young MJ 2009 Purification and characterization of recombinant human mineralocorticoid receptor. Molecular and Cellular Endocrinology 302 81-85.
18. Costello-Boerrigter LC, Boerrigter G, Harty GJ, Cataliotti A, Redfield MM & Burnett JC Jr 2007 Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction. Hypertension 50 481-488. (Pubitemid 47312233)
19. Dai Y, Ngo D, Forman LW, Qin DC, Jacob J & Faller DV 2007 Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Molecular Endocrinology 21 1807-1821. (Pubitemid 47173793)
20. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ & Yamamoto KR 1998 Structure and specificity of nuclear receptor-coactivator interactions. Genes and Development 12 3343-3356. (Pubitemid 28520983)
21. Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ & Stallcup MR 1998 Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Molecular Endocrinology 12 302-313. (Pubitemid 30658245)
22. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER & Monder C 1988 Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2 986-989. (Pubitemid 18254266)
23. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D & Rafestin-Oblin ME 1998 Antagonism in the human mineralocorticoid receptor. EMBO Journal 17 3317-3325.
24. Fagart J, Huyet J, Pinon GM, Rochel M, Mayer C & Rafestin-Oblin M-E 2005 Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nature Structural and Molecular Biology 12 554-555. (Pubitemid 43085888)
25. Farman N & Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. American Journal of Physiology. Renal Physiology 280 F181-F192.
26. Funder JW 2005 The nongenomic actions of aldosterone. Endocrine Reviews 26 313-321.
27. Funder JW 2007 The role of aldosterone and mineralocorticoid receptors in cardiovascular disease. American Journal of Cardiovascular Drugs 7 151-157. (Pubitemid 47047985)
28. Funder JW, Pearce PT, Smith R & Smith AI 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 583-585. (Pubitemid 18263202)
29. Fuse H, Kitagawa H & Kato S 2000 Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Molecular Endocrinology 14 889-899. (Pubitemid 32260501)
30. Galigniana MD, Piwien Pilipuk G, Kanelakis KC, Burton G & Lantos CP 2004 Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnanesteroids. Molecular and Cellular Endocrinology 217 167-179. (Pubitemid 38596641)
31. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FTF, Sigler PB & Lifton RP 2000 Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289 119-123. (Pubitemid 30463305)
32. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT & Gomez-Sanchez EP 2006 Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 147 1343-1348. (Pubitemid 43244368)
33. Goodson M, Jonas BA & Privalsky MA 2005 Corepressors: custom tailoring and alterations while you wait. Nuclear Receptor Signaling 3 e003.
34. Gottlicher M, Heck S, Doucas V, Wade E, Kullmann M, Cato AC, Evans RM & Herrlich P 1996 Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor. Steroids 61 257-262. (Pubitemid 126335269)
35. Govindan MV & Warriar N 1998 Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. Journal of Biological Chemistry 273 24439-24447. (Pubitemid 28454936)
36. Gross M, Liu B, Tan J, French FS, Carey M & Shuai K 2001 Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20 3880-3887. (Pubitemid 32646198)
37. Hall JM & McDonnell DP 2005 Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Molecular Interventions 5 343-357.
38. Handschin C & Spiegelman BM 2006 Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocrine Reviews 27 728-735. (Pubitemid 44936056)
39. He B, Kemppainen JA & Wilson EM 2000 FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. Journal of Biological Chemistry 275 22986-22994. (Pubitemid 30646187)
40. Heemers HV & Tindall DJ 2007 Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocrine Reviews 28 778-808.
41. Heery DM, Kalkhoven E, Hoare S & Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 733-736. (Pubitemid 27270617)
42. Hellal-Levy C, Fagart J, Souque A & Rafestin-Oblin ME 2000a Mechanistic aspects of mineralocorticoid receptor activation. Kidney International 57 1250-1255. (Pubitemid 30207874)
43. Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D & Rafestin-Oblin ME 2000b Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Molecular Endocrinology 14 1210-1221. (Pubitemid 32260482)
44. Hong H, Kohli K, Garabedian MJ & Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Molecular and Cellular Biology 17 2735-2744. (Pubitemid 27175156)
45. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK et al. 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377 397-404.
46. Hu X & Lazar MA 1999 The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402 93-96. (Pubitemid 29533522)
47. Hultman ML, Krasnoperova NV, Li S, Du S, Xia C, Dietz JD, Lala DS, Welsch DJ & Hu X 2005 The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms. Molecular Endocrinology 19 1460-1473. (Pubitemid 41002978)
48. Ikonen T, Palvimo JJ & Janne OA 1997 Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. Journal of Biological Chemistry 272 29821-29828. (Pubitemid 27508079)
49. Jackson PK 2001 A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes and Development 15 3053-3058.
50. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A & Redelmeier DA 2004 Rates of hyperkalemia after publication of the randomized aldactone evaluation study. New England Journal of Medicine 351 543-551. (Pubitemid 39025171)
51. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T & Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Molecular and Cellular Biology 22 3698-3706. (Pubitemid 34525213)
52. de Kloet ER, Joels M & Holsboer F 2005 Stress and the brain: from adaptation to disease. Nature Reviews. Neuroscience 6 463-475.
53. Knutti D & Kralli A 2001 PGC-1, a versatile coactivator. Trends in Endocrinology and Metabolism 12 360-365.
54. Knutti D, Kaul A & Kralli A 2000 A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Molecular and Cellular Biology 20 2411-2422. (Pubitemid 30152049)
55. Ko L, Cardona GR, Henrion-Caude A & Chin WW 2002 Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Molecular and Cellular Biology 22 357-369. (Pubitemid 33144281)
56. van der Laan S & Meijer OC 2008 Pharmacology of glucocorticoids: beyond receptors. European Journal of Pharmacology 585 483-491.
57. Lavery DN & McEwan IJ 2005 Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochemical Journal 391 449-464.
58. Lee S-K, Anzick SL, Choi J-E, Bubendorf L, Guan X-Y, Jung Y-K, Kallioniemi OP, Kononen J, Trent JM, Azorsa D et al. 1999 A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. Journal of Biological Chemistry 274 34283-34293. (Pubitemid 129511770)
59. Leygue E, Dotzlaw H, Watson PH & Murphy LC 1999 Expression of the steroid receptor RNA activator in human breast tumors. Cancer Research 59 4190-4193. (Pubitemid 29418723)
60. L'Horset F, Dauvois S, Heery DM, Cavailles V & Parker MG 1996 RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Molecular and Cellular Biology 16 6029-6036. (Pubitemid 26360962)
61. Li Y, Suino K, Daugherty J & Xu HE 2005 Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Molecular Cell 19 367-380. (Pubitemid 41074892)
62. Li J, Fu J, Toumazou C, Yoon H-G & Wong J 2006 A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin. Molecular Endocrinology 20 776-785.
63. Lin J, Handschin C & Spiegelman BM 2005 Metabolic control through the PGC-1 family of transcription coactivators. Cell Metabolism 1 361-370. (Pubitemid 43960626)
64. Lombes M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlanger BF & Gasc JM 1990 Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone. PNAS 87 1086-1088. (Pubitemid 20057170)
65. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N & Bonvalet JP 1992 Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circulation Research 71 503-510.
66. Lombes M, Binart N, Delahaye F, Baulieu EE & Rafestin-Oblin ME 1994a Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists. Biochemical Journal 302 191-197. (Pubitemid 24256354)
67. Lombes M, Kenouch S, Souque A, Farman N & Rafestin-Oblin ME 1994b The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase. Endocrinology 135 834-840. (Pubitemid 24271168)
68. Lombes M, Farman N, Bonvalet JP & Zennaro MC 2000 Identification and role of aldosterone receptors in the cardiovascular system. Annales d'Endocrinologie 61 41-46. (Pubitemid 30246167)
69. Lonard DM 2007 Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Molecular Cell 27 691-700.
70. Lonard DM & O'Malley BW 2006 The expanding cosmos of nuclear receptor coactivators. Cell 125 411-414.
71. Lonard DM, Lanz RB & O'Malley BW 2007 Nuclear receptor coregulators and human disease. Endocrine Reviews 28 575-587. (Pubitemid 47236337)
72. Losel R & Wehling M 2003 Nongenomic actions of steroid hormones. Nature Reviews Molecular Cell Biology 4 46-56.
73. McEwan IJ, Lavery D, Fischer K & Watt K 2007 Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nuclear Receptor Signaling 5 e001.
74. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N et al. 1998 Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes and Development 12 3357-3368. (Pubitemid 28520984)
75. McKenna NJ & O'Malley BW 2000 From ligand to response: generating diversity in nuclear receptor coregulator function. Journal of Steroid Biochemistry and Molecular Biology 74 351-356. (Pubitemid 32126246)
76. Meijer OC 2002 Coregulator proteins and corticosteroid action in the brain. Journal of Neuroendocrinology 14 499-505.
77. Meijer OC, Kalkhoven E, van der Laan S, Steenbergen PJ, Houtman SH, Dijkmans TF, Pearce D & de Kloet ER 2005 Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 146 1438-1448. (Pubitemid 40289333)
78. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M & Gannon F 2003 Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 751-763. (Pubitemid 38030303)
79. Mihailidou AS, Mardini M & Funder JW 2004 Rapid, Nongenomic effects of aldosterone in the heart mediated by {epsilon} protein kinase C. Endocrinology 145 773-780.
80. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A & Watson PH 2000 Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Research 60 6266-6271. (Pubitemid 30952120)
81. Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD & Montminy M1997 RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90 1107-1112.
82. Nakshatri H, Bhat-Nakshatri P & Currie RA 1996 Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. Journal of Biological Chemistry 271 28784-28791. (Pubitemid 26382574)
83. Obradovic D, Tirard M, Nemethy Z, Hirsch O, Gronemeyer H & Almeida OFX 2004 DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells: toward a basis for the opposite actions elicited by two nuclear receptors? Molecular Pharmacology 65 761-769.
84. Ogryzko VV, Schiltz RL, Russanova V, Howard BH & Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 953-959. (Pubitemid 26404293)
85. O'Malley BW 2007 Coregulators: from whence came these 'master genes'. Molecular Endocrinology 21 1009-1013.
86. Onate SA, Tsai SY, Tsai M-J & O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science v270 1354.
87. Ortlund EA, Bridgham JT, Redinbo MR & Thornton JW 2007 Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317 1544-1548.
88. Pascual-Le Tallec L, Kirsh O, Lecomte M-C, Viengchareun S, Zennaro M-C, Dejean A & Lombes M 2003 Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Molecular Endocrinology 17 2529-2542. (Pubitemid 37542215)
89. Pascual- Le Tallec L, Simone F, Viengchareun S, Meduri G, Thirman MJ & Lombes M 2005 The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions. Molecular Endocrinology 19 1158-1169. (Pubitemid 40594116)
90. Pearce D, Bhargava A & Cole TJ 2003 Aldosterone: its receptor, target genes, and actions. Vitamins and Hormone 66 29-76. (Pubitemid 137640983)
91. Perissi V, Aggarwal A, Glass CK, Rose DW & Rosenfeld MG 2004 A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116 511-526. (Pubitemid 38264429)
92. Pippal J & Fuller P 2008 Structure-function relationships in the mineralocorticoid receptor. Journal of Molecular Endocrinology 41 405-413.
93. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J & The Randomized Aldactone Evaluation Study I 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine 341 709-717.
94. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M et al. 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine 348 1309-1321. (Pubitemid 36384098)
95. Portilla D, Dai G, McClure T, Bates L, Kurten R, Megyesi J, Price P & Li S 2002 Alterations of PPAR[agr] and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney International 62 1208-1218.
96. Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ & Janne OA 1999 Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. Journal of Biological Chemistry 274 19441-19446. (Pubitemid 129519379)
97. Puigserver P, Wu Z, Park CW, Graves R, Wright M & Spiegelman BM 1998 A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 829-839. (Pubitemid 28155321)
98. Rogers RS, Horvath CM & Matunis MJ 2003 SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. Journal of Biological Chemistry 278 30091-30097.
99. Rogerson FM & Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Molecular and Cellular Endocrinology 200 45-55.
100. Rogerson FM, Brennan FE & Fuller PJ 2003 Dissecting mineralocorticoid receptor structure and function. Journal of Steroid Biochemistry and Molecular Biology 85 389-396. (Pubitemid 37011115)
101. Rogerson FM, Yao Y, Smith BJ & Fuller PJ 2004 Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor. Clinical and Experimental Pharmacology and Physiology 31 704-709. (Pubitemid 39540321)
102. Rowan BG & O'Malley BW 2000 Progesterone receptor coactivators. Steroids 65 545-549.
103. Seeler J-S & Dejean A 2003 Nuclear and unclear functions of SUMO. Nature Reviews. Molecular Cell Biology 4 690-699.
104. Shang Y & Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295 2465-2468. (Pubitemid 34270263)
105. Shapiro BP, Owan TE, Mohammed S, Kruger M, Linke WA, Burnett JC Jr & Redfield MM 2008 Mineralocorticoid signaling in transition to heart failure with normal ejection fraction. Hypertension 51 289-295. (Pubitemid 351159941)
106. Shen HC, Buchanan G, Butler LM, Prescott J, Henderson M, Tilley WD & Coetzee GA 2005 GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor. Biological Chemistry 386 69-74. (Pubitemid 40361453)
107. Shibata H, Murai-Takeda A, Yokota K, Kurihara I, Kobayashi S, Mitsubishi Y, Kitagawa H, Kato S, Saruta T & Itoh H. 2008 A repressive role for NF-YC in aldosterone signalling. Keystone Symposia on Molecular and Cellular Biology. Abstract Book, Whistler. 170.
108. Shilatifard A 1998 Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB Journal 12 1437-1446. (Pubitemid 28506712)
109. Shilatifard A, Conaway RC & Conaway JW 2003 The RNA polymerase II elongation complex. Annual Review of Biochemistry 72 693-715.
110. Smith CL & O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocrine Reviews 25 45-71.
111. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ et al. 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389 194-198. (Pubitemid 27400603)
112. Sugiyama T, Yoshimoto T, Tsuchiya K, Gochou N, Hirono Y, Tateno T, Fukai N & Shichiri M 2005 Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. Endocrinology 146 3900-3906. (Pubitemid 41175760)
113. Sutanto W & de Kloet KR 1991 Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects. Medicinal Research Reviews 11 617-639.
114. Szapary D, Huang Y & Simons SS Jr 1999 Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Molecular Endocrinology 13 2108-2121. (Pubitemid 30637270)
115. Tallec LP-L & Lombes M 2005 The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Molecular Endocrinology 19 2211-2221. (Pubitemid 41252817)
116. Tallec LP-L, Kirsh O, Lecomte M-C, Viengchareun S, Zennaro M-C, Dejean A & Lombes M 2003 Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Molecular Endocrinology 17 2529-2542. (Pubitemid 37542215)
117. Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K & French FS 2000 Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Molecular Endocrinology 14 14-26. (Pubitemid 32266064)
118. Thenot S, Henriquet C, Rochefort H & Cavailles V 1997 Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. Journal of Biological Chemistry 272 12062-12068. (Pubitemid 27202785)
119. Torii S, Egan DA, Evans RA & Reed JC 1999 Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO Journal 18 6037-6049. (Pubitemid 29515680)
120. Voegel JJ, Heine MJ, Zechel C, Chambon P & Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO Journal 15 3667-3675. (Pubitemid 26239779)
121. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P & Gronemeyer H 1998 The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO Journal 17 507-519. (Pubitemid 28045491)
122. Wang Q, Anzick S, Richter WF, Meltzer P & Simons SS Jr 2004a Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors. Journal of Steroid Biochemistry and Molecular Biology 91 197-210. (Pubitemid 39164603)
123. Wang Q, Blackford JA Jr, Song L-N, Huang Y, Cho S & Simons SS Jr 2004b Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Molecular Endocrinology 18 1376-1395. (Pubitemid 38692177)
124. Warnmark A, Treuter E, Wright APH & Gustafsson J-A 2003 Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Molecular Endocrinology 17 1901-1909. (Pubitemid 37287610)
125. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D & Gronemeyer H 1996 A canonical structure for the ligand-binding domain of nuclear receptors. Nature Structural Biology 3 206. (Pubitemid 126664322)
126. Xu J & Li Q 2003 Review of the in vivo functions of the p160 steroid receptor coactivator family. Molecular Endocrinology 17 1681-1692. (Pubitemid 37072287)
127. Yang X, Khosravi-Far R, Chang HY & Baltimore D 1997 Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89 1067-1076. (Pubitemid 127678740)
128. Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai-Takeda A, Saito I, Kitagawa H, Kato S, Saruta T et al. 2007 Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. Journal of Biological Chemistry 282 1998-2010. (Pubitemid 47076701)
129. Young M & Funder JW 2000 Aldosterone and the heart. Trends in Endocrinology and Metabolism 11 224-226.
130. Young MJ, Lam EY & Rickard AJ 2007 Mineralocorticoid receptor activation and cardiac fibrosis. Clinical Science 112 467-475. (Pubitemid 46762007)
131. Yudt MR & Cidlowski JA 2002 The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Molecular Endocrinology 16 1719-1726.
132. Zennaro MC, Le Menuet D & Lombes M 1996 Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms. Molecular Endocrinology 10 1549-1560. (Pubitemid 26408744)
133. Zennaro MC, Farman N, Bonvalet JP & Lombes M 1997 Tissue-specific expression of alpha and beta messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states. Journal of Clinical Endocrinology and Metabolism 82 1345-1352. (Pubitemid 27200399)
134. Zennaro MC, Souque A, Viengchareun S, Poisson E & Lombes M 2001 A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Molecular Endocrinology 15 1586-1598. (Pubitemid 32826411)